These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 11528361

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.
    Scarabin PY, Alhenc-Gelas M, Plu-Bureau G, Taisne P, Agher R, Aiach M.
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3071-8. PubMed ID: 9409295
    [Abstract] [Full Text] [Related]

  • 6. Transdermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease.
    Lindoff C, Peterson F, Lecander I, Martinsson G, Astedt B.
    Maturitas; 1996 May; 24(1-2):43-50. PubMed ID: 8794433
    [Abstract] [Full Text] [Related]

  • 7. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S, Silveira A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Järvinen H.
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [Abstract] [Full Text] [Related]

  • 8. Substitution of transdermal estradiol during oral estrogen-progestin therapy in postmenopausal women: effects on hypertriglyceridemia.
    Sanada M, Tsuda M, Kodama I, Sakashita T, Nakagawa H, Ohama K.
    Menopause; 2004 Apr; 11(3):331-6. PubMed ID: 15167313
    [Abstract] [Full Text] [Related]

  • 9. Influence of two hormone replacement therapy regimens, oral oestradiol valerate and cyproterone acetate versus transdermal oestradiol and oral dydrogesterone, on lipid metabolism.
    Schram JH, Boerrigter PJ, The TY.
    Maturitas; 1995 Sep; 22(2):121-30. PubMed ID: 8538480
    [Abstract] [Full Text] [Related]

  • 10. Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response.
    Raudaskoski T, Tapanainen J, Tomás E, Luotola H, Pekonen F, Ronni-Sivula H, Timonen H, Riphagen F, Laatikainen T.
    BJOG; 2002 Feb; 109(2):136-44. PubMed ID: 11888095
    [Abstract] [Full Text] [Related]

  • 11. Changes in normal lipid profile of menopausal women with combined hormone replacement therapy. Comparative clinical trial of two hormonal combinations (conjugated estrogens/medroxyprogesterone acetate versus estradiol valerate/cyproterone acetate).
    Alwers R, Urdinola J, Onatra W, Sánchez F, Posso H.
    Maturitas; 1999 May 31; 32(1):41-50. PubMed ID: 10423715
    [Abstract] [Full Text] [Related]

  • 12. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.
    Bhathena RK, Anklesaria BS, Ganatra AM, Pinto R.
    Br J Clin Pharmacol; 1998 Feb 31; 45(2):170-2. PubMed ID: 9491833
    [Abstract] [Full Text] [Related]

  • 13. Short-term results of transdermal estrogen replacement therapy in cardiovascular disease-free postmenopausal females with and without hypertension.
    Modena MG, Rossi R, Muia N, Origliani G, Rombolà O, Molinari R.
    G Ital Cardiol; 1998 Jun 31; 28(6):636-44. PubMed ID: 9672776
    [Abstract] [Full Text] [Related]

  • 14. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec 31; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 15. Effects of postmenopausal estrogen/progestin replacement therapy on LDL particles; comparison of transdermal and oral treatment regimens.
    Lahdenperä S, Puolakka J, Pyörälä T, Luotola H, Taskinen MR.
    Atherosclerosis; 1996 May 31; 122(2):153-62. PubMed ID: 8769679
    [Abstract] [Full Text] [Related]

  • 16. Double blind, randomized study of estradiol replacement therapy on markers of inflammation, coagulation and fibrinolysis.
    Zegura B, Keber I, Sebestjen M, Koenig W.
    Atherosclerosis; 2003 May 31; 168(1):123-9. PubMed ID: 12732395
    [Abstract] [Full Text] [Related]

  • 17. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.
    Godsland IF.
    Fertil Steril; 2001 May 31; 75(5):898-915. PubMed ID: 11334901
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Changes in the lipoprotein profile in postmenopausal women receiving hormone replacement therapy. Effects of natural and synthetic progesterone.
    Chen FP, Lee N, Soong YK.
    J Reprod Med; 1998 Jul 31; 43(7):568-74. PubMed ID: 9693406
    [Abstract] [Full Text] [Related]

  • 20. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
    Sendag F, Karadadas N, Ozsener S, Bilgin O.
    Arch Gynecol Obstet; 2002 Jan 31; 266(1):38-43. PubMed ID: 11998963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.